Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Mar 2026.
- Largest single sale: $107K (200 shares) of United Therapeutics Corp on Mar 16, 2026. Filing
- Last sale before this period: Sep 19, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ares Management (ARES) | Director | May 5, 2014 | Aug 3, 2026 |
| United Therapeutics Corp (UTHR) | Director | Jun 29, 2015 | Jul 23, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 30, 2026, Ares Management: 1,728 shares awarded. 1 filing: 1
- Jul 9, 2026, United Therapeutics Corp: 1,310 shares vested. 1 filing: 1
- Mar 23, 2026, United Therapeutics Corp: sold 200 shares for $106K, under a disclosed plan. 1 filing: 1
- Mar 16, 2026, United Therapeutics Corp: sold 200 shares for $107K, under a disclosed plan. 1 filing: 1
- Mar 6, 2026, United Therapeutics Corp: sold 200 shares for $102K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.